Work

Figure 7 from Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical Study

Year: 2025

Type: other

Abstract: Pharmacokinetics of Acetalax in plasma, tumor and several organs from PDX HBCx-158. A, Plasma concentrations of oxyphenisatin vs. time curve. B, Concentrations of oxyphenisatin in tumor vs. time. C, Concentrations of oxyphenisatin in brain vs. time. The squares depict one standard deviation for the results and the line the mean.

DOI: 10.1158/2767-9764.28512656

Authors: William C. Reinhold, Elisabetta Marangoni, Fathi Elloumi, Remi Montagne, Sudhir Varma, Yanghsin Wang, Keyvan Rezai, Ludivine Morriset, Ahmed Dahmani, Rania El Botty, Léa Huguet, Makito Mizunuma, Naoko Takebe, Samuel Huguet, Augustin Luna, Yves Pommier

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4408033926

Cites:

Cited by:

Related to: 10